Ocular Therapeutix Inc (OCUL)

EBITDA Growth

-16.23%

Quarterly · Period ending:

OCUL logo

OCUL EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-16.23%
OCUL Quarterly EBITDA YoY % (-132.32% → -16.23%)
High-resolution chart · PNG

OCUL ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ocular Therapeutix Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-16.2266%
-40.7136%
-36.6425%
-102.2501%
-60.9388%
-0.3524%
-83.8621%
-950.2632%
-119.663%
-113.3359%
-82.6038%
117.3659%
-9.2081%
-172.4422%
-725.25%
-545.7527%
-165.7763%
-289.1664%
98.0774%
151.3279%
81.8099%
128.4461%
-253.5517%
41.8884%
-52.4292%
-24.8858%
-43.1491%
-17.4481%
-75.3501%
-20.5757%
-36.0725%
3.9811%
28.4747%
17.005%
0.5514%
-62.9886%
-63.9633%
-48.6704%
-20.6055%
18.4517%
-15.3683%
-48.4726%
-36.4621%
-62.0425%
-58.8967%
-0.9895%
-124.4755%
-103.1175%
-105.8152%
-132.3191%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.